Omalizumab-induced decrease of FcɛRI expression in patients with severe allergic asthma-Reference-Cited by-同舟云学术

Omalizumab-induced decrease of FcɛRI expression in patients with severe allergic asthma

Published:2010-11 Issue:11 Volume:104 Page:1608-1617
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Chanez Pascal,Contin-Bordes Cécile,Garcia Gilles,Verkindre Christophe,Didier Alain,De Blay Frédéric,Tunon de Lara Manuel,Blanco Patrick,Moreau Jean-François,Robinson Philip,Bourdeix Isabelle,Trunet Patrick,Le Gros Vincent,Humbert Marc,Molimard Mathieu

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference27 articles.

1. Allergy and the lung;Passalacqua;Clin Exp Immunol,2008

2. Risk factors and characteristics associated with severe and difficult to treat asthma phenotype: an analysis of the ENFUMOSA group of patients based on the ECRHS questionnaire;Gaga;Clin Exp Allergy,2005

3. Asthma;Busse;N Engl J Med,2001

4. The role of immunoglobulin E in allergy and asthma;Platts-Mills;Am J Respir Crit Care Med,2001

5. The pharmacological basis of anti-IgE therapy;Chang;Nat Biotechnol,2000

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basophil FceRI expression—A management tool in anti‐IgE treatment of allergic asthma;Pediatric Pulmonology;2024-08-07

2. Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials;European Respiratory Review;2024-04-24

3. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database;BioDrugs;2024-03-15

4. The airway epithelium: an orchestrator of inflammation, a key structural barrier and a therapeutic target in severe asthma;European Respiratory Journal;2024-03-07

5. Effects of omalizumab on lung function in patients with moderate-to-severe allergic asthma: a systematic review and meta-analysis;Therapeutic Advances in Respiratory Disease;2024-01